Form 8-K - Current report:
SEC Accession No. 0000950123-11-024139
Filing Date
2011-03-10
Accepted
2011-03-10 16:19:09
Documents
3
Period of Report
2011-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c13873e8vk.htm 8-K 8743
2 EXHIBIT 99.1 c13873exv99w1.htm EX-99.1 39346
3 GRAPHIC c13873c1387300.gif GRAPHIC 3145
  Complete submission text file 0000950123-11-024139.txt   53785
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 11678712
SIC: 2835 In Vitro & In Vivo Diagnostic Substances